Recent progress in the battle between oncolytic viruses and tumours von Bell, John C, Parato, Kelley A, Senger, Donna, Forsyth, Peter A. J

Volltext

Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral Immunity von Power, Anthony T, Wang, Jiahu, Falls, Theresa J, Paterson, Jennifer M, Parato, Kelley A, Lichty, Brian D, Stojdl, David F, Forsyth, Peter A J, Atkins, Harry, Bell, John C

Volltext

Changing recognition of breast cancer–related leptomeningeal disease and response to therapy: A retrospective single institution review von Wallace, Gerald Carter, Ahmed, Kamran A., Soyano Muller, Aixa Elena, Forsyth, Peter A. J.

Volltext

Factors associated with overall survival in patients with melanoma leptomeningeal disease (M-LMD): A single institution retrospective review von Nyman, Karl, Kundalia, Ronak, Ospina, Oscar, Wallace, Gerald Carter, Pina, Yolanda, Smalley, Inna, Forsyth, Peter A. J.

Volltext

Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype? von Senger, Donna, Cairncross, J Gregory, Forsyth, Peter A J

Volltext

Detection of targetable somatic alterations in glioblastoma (GBM) and clinical impact von Fusco, Michael, Macaulay, Robert J, Forsyth, Peter A. J., Walko, Christine Marie

Volltext

Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from triple negative breast cancer or HER2 + breast... von Gandhi, Shipra, Forsyth, Peter A. J., Opyrchal, Mateusz, Ahmed, Kamran A., Attwood, Kristopher, Levine, Ellis Glenn, O'Connor, Tracey L., Early, Amy P., Fenstermaker, Robert Alan, Prasad, Dheerendra, Takabe, Kazuaki, Czerniecki, Brian J., Kalinski, Pawel

Volltext

Phase 1B study of avelumab and whole brain radiotherapy (WBRT) in patients with leptomeningeal disease (LMD) from epithelial carcinomas: Final results and molecular analyses with s... von Pina, Yolanda, Chen, Ann, Arrington, John, Macaulay, Robert J, Tran, Nam D., Liu, James K, Mokhtari, Sepideh, Li, Jiannong, Law, Vincent, Sahebjam, Solmaz, Ahmed, Kamran A., Creelan, Ben C., Gray, Jhanelle Elaine, Evernden, Brittany, Khushalani, Nikhil I., Smalley, Inna, Vogelbaum, Michael A., Yu, Michael, Smalley, Keiran, Forsyth, Peter A. J.

Volltext

Trial in progress: Phase I/II study of radiation therapy followed by intrathecal trastuzumab/pertuzumab in the management of HER2 + breast leptomeningeal disease von Ahmed, Kamran A., Kim, Youngchul, DeJesus, Michelle, Kumthekar, Priya, Williams, Nicole Olivia, Palmer, Joshua David, Giglio, Pierre, Boire, Adrienne Ann, Arrington, John, Sahebjam, Solmaz, Rosa, Marilin, Soliman, Hatem Hussein, Yu, Hsiang-Hsuan Michael, Han, Hyo S., Forsyth, Peter A. J.

Volltext

Relationship of the p75 neurotrophin receptor (p75NTR) and hypoxic response and treatment resistance in malignant gliomas von Kenchappa, Rajappa, Forsyth, Peter A. J.

Volltext

Intramuscular (IM) INO-5401 + INO-9012 with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma von Reardon, David A., Brem, Steven, Desai, Arati Suvas, Bagley, Stephen Joseph, Kurz, Sylvia Christine, De La Fuente, Macarena Ines, Nagpal, Seema, Welch, Mary Roberta, Hormigo, Adilia, Forsyth, Peter A. J., Mandel, Jacob Joseph, Khagi, Simon, Aiken, Robert, Walbert, Tobias, Lieberman, Frank S., Portnow, Jana, Battiste, James, Gillespie, Elisabeth, Lowy, Israel, Skolnik, Jeffrey

Volltext

Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: A non-randomized, open-label phase Ib study von Ahmed, Kamran A., Kim, Youngchul, Arrington, John, Kim, Sungjune, DeJesus, Michelle, Soyano, Aixa, Armaghani, Avan J., Costa, Ricardo L, Khong, Hung T., Rosa, Marilin, Caudell, Jimmy J., Diaz, Roberto, Robinson, Timothy J., Etame, Arnold B., Tran, Nam D., Sahebjam, Solmaz, Soliman, Hatem Hussein, Forsyth, Peter A. J., Yu, Hsiang-Hsuan Michael, Han, Hyo S.

Volltext

Presentation and management of patients with brain metastases of primary melanoma, non-small cell lung cancer, and breast cancer origin von Kawahara, Yuki, Mills, Matthew, Potluri, Thrisha, Fahey, Matthew, Figura, Nicholas B, Soyano, Aixa, Washington, Iman, Diaz, Roberto, Oliver, Daniel Eli, Yu, Hsiang-Hsuan Michael, Etame, Arnold B., Vogelbaum, Michael A., Czerniecki, Brian J., Arrington, John, Sahebjam, Solmaz, Soliman, Hatem Hussein, Forsyth, Peter A. J., Han, Hyo S., Ahmed, Kamran A.

Volltext

Trial in progress: Phase 1a/b study of PF-07284890 (brain-penetrant BRAF inhibitor) with/without binimetinib in patients with BRAF V600-mutant solid tumors von Subbiah, Vivek, Gutierrez, Martin, Anders, Carey K., Ansstas, George, Owonikoko, Taofeek K., Monga, Varun, Forsyth, Peter A. J., Dagogo-Jack, Ibiayi, Chandra, Sunandana, Tsai, Katy K., Diamond, Eli L., McKean, Meredith, Buchbinder, Elizabeth Iannotti, Nepert, Dale, Ingram, Kim, Oliver, Colleen, Reddy, Micaela, Maharry, Kati, Xing, Yan

Volltext

Effect of inhibition of α-secretase activity on cleavage of p75 neurotrophin receptor (p75NTR) and proliferation of brain tumor initiating cells (BTICs) and malignant gliomas (MGs)... von Kenchappa, Rajappa, Krishna, Niveditha, Forsyth, Peter A. J.

Volltext

M011L-deficient oncolytic myxoma virus to induce apoptosis in brain tumor initiating cells and to enhance survival in a novel immunocompetent mouse model of glioblastoma von Kenchappa, Rajappa, McKenzie, Brienne, Pisklakova, Alexandra, McFadden, Grant, Forsyth, Peter A. J.

Volltext

Neurotrophin signaling and melanoma brain metastases von Fortenbery, Nicole, Kenchappa, Rajappa, Forsyth, Peter A. J.

Volltext

Detection, molecular profiling and culture of CSF-CTCs in leptomeningeal disease (LMDz) in melanoma von Forsyth, Peter A. J., Evernden, Brittany, Law, Vincent, Kenchappa, Rajappa, Puskas, John, Ryzhova, Elena, Smalley, Inna, Tran, Nam D., Etame, Arnold B, Sahebjam, Solmaz, Magliocco, Anthony Martin, Smalley, Keiran

Volltext

Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204) von Tawbi, Hussein Abdul-Hassan, Forsyth, Peter A. J., Hodi, F. Stephen, Lao, Christopher D., Moschos, Stergios J., Hamid, Omid, Atkins, Michael B., Lewis, Karl D., Thomas, Reena Parada, Glaspy, John A., Jang, Sekwon, Algazi, Alain Patrick, Khushalani, Nikhil I., Postow, Michael A., Pavlick, Anna C., Ernstoff, Marc S., Reardon, David A., Balogh, Agnes, Rizzo, Jasmine I., Margolin, Kim Allyson

Volltext

Nivolumab combined with hypofractionated stereotactic irradiation (HFSRT) for patients with recurrent high grade gliomas: A phase I trial (NCT02829931) von Sahebjam, Solmaz, Forsyth, Peter A. J., Arrington, John, Tran, Nam D., Jaglal, Michael Vishal, Mokhtari, Sepideh, Long, Wendy, Macaulay, Robert J, Wicklund, Melissa, Drury-Sibiga, Ali, Gatewood, Tyra, Robinson, Timothy J., Raval, Raju R., Yu, Michael

Volltext